BMY FY 2012 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$122B

FY 2012 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$17.6B-17.1% YoY

Gross Profit

$13.2B74.8% margin

Operating Income

$4.3B24.2% margin

Net Income

$2.0B11.1% margin

EPS (Diluted)

$1.16

Cash Flow

Operating Cash Flow

$6.9B

Free Cash Flow

$6.4B

Stock-Based Comp.

$154M

Balance Sheet

Total Assets

$35.9B

Total Liabilities

$22.3B

Stockholders' Equity

$13.6B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17.6B	$21.2B	-17.1%
Gross Profit	$13.2B	$15.7B	-16.1%
Operating Income	$4.3B	$6.8B	-36.8%
Net Income	$2.0B	$3.7B	-47.2%